Income Statement (TTM)
EyePoint Pharmaceuticals, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 34 | 34 | 39 | 33 | 37 | 39 | 41 | 42 | 41 | 40 | 37 | 43 | 46 | 50 | 50 | 46 | 43 | 56 | 52 |
| Change (%) | -4.18 | -0.48 | 14.27 | -16.94 | 13.57 | 5.34 | 6.56 | 2.30 | -2.38 | -3.89 | -6.18 | 13.90 | 8.22 | 8.69 | 0.74 | -9.28 | -5.34 | 29.51 | -7.39 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 21 | 23 | 24 | 28 | 32 | 36 | 41 | 48 | 50 | 58 | 61 | 63 | 69 | 68 | 84 | 98 | 109 | 134 | 162 | 186 |
| Change (%) | 10.51 | 4.46 | 15.47 | 15.52 | 11.36 | 13.01 | 17.06 | 4.20 | 16.58 | 4.65 | 4.04 | 9.42 | -1.35 | 24.00 | 16.35 | 11.23 | 22.47 | 20.77 | 14.78 | |
| % of Revenue | 58.54 | 67.51 | 70.86 | 71.60 | 99.59 | 97.65 | 104.77 | 115.09 | 117.23 | 140.01 | 152.45 | 169.06 | 162.41 | 148.05 | 168.89 | 195.06 | 239.17 | 309.43 | 288.54 | 357.63 |
| Gross Operating Profit | 15 | 11 | 10 | 11 | 0 | 1 | -2 | -6 | -7 | -17 | -21 | -26 | -27 | -22 | -34 | -48 | -64 | -91 | -106 | -134 |
| Change (%) | -24.92 | -10.74 | 11.36 | -98.80 | 547.76 | -313.71 | 237.30 | 16.80 | 126.66 | 26.00 | 23.54 | 2.94 | -16.68 | 55.84 | 39.01 | 32.81 | 42.45 | 16.59 | 26.54 | |
| % of Revenue | 41.46 | 32.49 | 29.14 | 28.40 | 0.41 | 2.35 | -4.77 | -15.09 | -17.23 | -40.01 | -52.45 | -69.06 | -62.41 | -48.05 | -68.89 | -95.06 | -139.17 | -209.43 | -188.54 | -257.63 |
| SG&A | 46 | 46 | 44 | 45 | 48 | 54 | 58 | 62 | 64 | 60 | 60 | 59 | 55 | 53 | 52 | 51 | 53 | 55 | 56 | 55 |
| Change (%) | 0.08 | -3.72 | 2.17 | 5.23 | 12.69 | 8.62 | 6.58 | 3.28 | -6.01 | -0.70 | -1.26 | -7.01 | -3.73 | -1.10 | -3.17 | 5.19 | 3.52 | 0.87 | -0.65 | |
| % of Revenue | 127.94 | 133.63 | 129.29 | 115.60 | 146.46 | 145.33 | 149.86 | 149.89 | 151.32 | 145.70 | 150.54 | 158.44 | 129.35 | 115.07 | 104.71 | 100.64 | 116.70 | 127.63 | 99.40 | 106.64 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 69 | 72 | 71 | 76 | 82 | 92 | 102 | 112 | 116 | 120 | 122 | 123 | 124 | 121 | 137 | 149 | 163 | 189 | 217 | 241 |
| Change (%) | 3.24 | -0.94 | 6.64 | 8.87 | 11.79 | 10.11 | 10.63 | 3.60 | 3.42 | 1.38 | 0.89 | 0.96 | -2.56 | 13.02 | 8.88 | 9.18 | 16.26 | 14.96 | 10.83 | |
| % of Revenue | 193.32 | 208.28 | 207.32 | 193.48 | 253.61 | 249.64 | 260.95 | 270.91 | 274.35 | 290.65 | 306.59 | 329.69 | 292.25 | 263.13 | 273.60 | 295.71 | 355.88 | 437.06 | 387.94 | 464.27 |
| Operating Income | -34 | -37 | -37 | -37 | -50 | -55 | -63 | -71 | -74 | -79 | -82 | -86 | -82 | -75 | -87 | -99 | -117 | -146 | -161 | -189 |
| Change (%) | 11.19 | -1.36 | -0.47 | 36.48 | 10.63 | 13.30 | 13.15 | 4.36 | 6.74 | 4.14 | 4.31 | -4.67 | -8.17 | 15.68 | 13.57 | 18.61 | 24.69 | 10.64 | 17.15 | |
| % of Revenue | -93.32 | -108.28 | -107.32 | -93.48 | -153.61 | -149.64 | -160.95 | -170.91 | -174.35 | -190.65 | -206.59 | -229.69 | -192.25 | -163.13 | -173.60 | -195.71 | -255.88 | -337.06 | -287.94 | -364.27 |
| Interest Expense | -7 | -7 | -7 | -6 | -6 | -5 | -5 | -5 | -4 | -3 | -3 | -3 | -2 | -1 | -0 | 0 | 0 | -0 | -0 | -0 |
| Change (%) | 0.55 | -6.04 | -6.31 | -7.07 | -7.39 | -2.76 | -15.43 | -16.04 | -15.99 | -11.98 | -4.13 | -24.64 | -38.51 | -65.12 | -100.00 | NaN | -∞ | -0.00 | -0.00 | |
| % of Revenue | -20.08 | -21.07 | -19.90 | -16.31 | -18.25 | -14.88 | -13.74 | -10.90 | -8.95 | -7.70 | -7.05 | -7.21 | -4.77 | -2.71 | -0.87 | 0.00 | 0.00 | -0.03 | -0.02 | -0.03 |
| Net Income | -40 | -45 | -44 | -42 | -54 | -58 | -67 | -77 | -78 | -102 | -102 | -106 | -100 | -71 | -79 | -87 | -104 | -131 | -147 | -175 |
| Change (%) | 12.54 | -1.97 | -6.61 | 31.03 | 7.28 | 14.89 | 14.00 | 2.25 | 30.70 | 0.18 | 3.43 | -5.48 | -29.31 | 11.47 | 10.02 | 19.29 | 26.36 | 12.16 | 19.48 | |
| % of Revenue | -112.23 | -131.82 | -129.85 | -106.12 | -167.42 | -158.14 | -172.48 | -184.53 | -184.45 | -246.97 | -257.44 | -283.81 | -235.51 | -153.84 | -157.77 | -172.29 | -226.57 | -302.43 | -261.91 | -337.93 |
Source: Capital IQ
